A detailed history of Td Asset Management Inc transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 9,534 shares of JANX stock, worth $518,554. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,534
Previous 19,800 51.85%
Holding current value
$518,554
Previous $829,000 47.77%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$35.29 - $50.26 $362,287 - $515,969
-10,266 Reduced 51.85%
9,534 $433,000
Q2 2024

Aug 02, 2024

BUY
$35.12 - $64.78 $695,376 - $1.28 Million
19,800 New
19,800 $829,000

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2.27B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.